Our venture investing activities are organized around two distinct practice areas — Life Sciences and Health Technology.
We invest in biotechnology companies leveraging breakthrough science to improve human health. Our interests encompass a broad spectrum of the life sciences, from therapeutics and diagnostics to tools and enabling technologies.
We invest in companies building novel technology-enabled solutions to improve access to care and health outcomes while reducing costs to individuals and the healthcare system.
Digitalis Portfolio Companies Are Hiring
See All Open Positions